Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
January 29, 2024 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
Recombinant Proteins Market revenue to hit USD 9 Billion by 2035, says Research Nester
January 25, 2024 05:30 ET
|
Research Nester
New York, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The global recombinant proteins market size is slated to expand at ~12.80% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 9...
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
January 23, 2024 08:00 ET
|
ProPhase Labs, Inc.
Pharmaloz Wins Two New Contracts in January that are Anticipated to Significantly Increase Lozenge Revenues and ProfitabilityCompany in Late-Stage Discussions with Two Additional Large Global Brands...
Automated Guided Vehicle Market in Middle East & Africa Expected to Surge, Reaching US$ 471.06 Million by 2030
January 21, 2024 21:18 ET
|
Research and Markets
Dublin, Jan. 21, 2024 (GLOBE NEWSWIRE) -- The "Middle East & Africa Automated Guided Vehicle Market Forecast to 2030 - Regional Analysis - by Technology, Vehicle Type, and End User" report has...
$106.55 Billion ADAS Market by Type, Automation Level, Component, Vehicle, End Use, and Geography - Global Forecast to 2030
January 16, 2024 06:33 ET
|
Research and Markets
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The "ADAS Market by Type, Automation, Component, Vehicle, End Use, and Geography - Global Forecast to 2030" report has been added to ...
$60.13B Predictive Maintenance Industry Assessment, 2023-2030: Lucrative Segments and Key Player Strategies Unveiled
January 11, 2024 12:48 ET
|
Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Predictive Maintenance Market Size, Share & Trends Analysis Report By Component, By Solution, By Service, By Deployment, By Enterprise Size, By...
Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets
January 08, 2024 08:00 ET
|
Gallant Therapeutics
Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
January 04, 2024 08:00 ET
|
ProPhase Labs, Inc.
Company also plans to commercialize its BE-Smart Esophageal Cancer Test in 2024Company announces the hiring of long-time industry veteran Jed Latkin as COO to help build and manage this growth Garden...
Wugen Strengthens Executive Leadership Team with Appointment of Keith Vendola, M.D., M.B.A. as Chief Financial Officer
January 03, 2024 08:00 ET
|
Wugen
Wugen Strengthens Executive Leadership Team with the Appointment of Keith Vendola, M.D., M.B.A. as Chief Financial Officer
Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option
December 21, 2023 16:00 ET
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option Closes acquisition of...